These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7004877)

  • 1. Successful acute and long-term treatment of renin-induced hypertension in two infants with captopril.
    Rosendahl W; Hayduk K
    Eur J Pediatr; 1980 Dec; 135(2):161-4. PubMed ID: 7004877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.
    Karlberg BE; Asplund J; Nilsson OR; Wettre S; Ohman KP
    Acta Med Scand; 1981; 209(4):245-52. PubMed ID: 7015795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril in severe treatment-resistant hypertension.
    Ferguson RK; Vlasses PH; Koplin JR; Shirinian A; Burke JF; Alexander JC
    Am Heart J; 1980 May; 99(5):579-85. PubMed ID: 6989221
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitor treatment of hypertension in infancy and childhood.
    Sigström L; Aurell M; Jodal U
    Scand J Urol Nephrol Suppl; 1984; 79():107-9. PubMed ID: 6089308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relief from malignant hypertension by treatment with captopril in a patient on maintenance hemodialysis.
    Witzgall H
    Klin Wochenschr; 1980 Sep; 58(17):871-3. PubMed ID: 7003235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.
    Stumpe KO; Overlack A; Kolloch R; Schreyer S
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):121S-126S. PubMed ID: 6291563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC
    Br Med J; 1979 Nov; 2(6198):1106-9. PubMed ID: 229941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of captopril and aprotinin on inactive renin.
    Sealey JE; Overlack A; Laragh JH; Stumpe KO; Atlas SA
    J Clin Endocrinol Metab; 1981 Sep; 53(3):626-30. PubMed ID: 6167591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients.
    Holland OB; von Kuhnert L; Campbell WB; Anderson RJ
    Hypertension; 1983; 5(2):235-9. PubMed ID: 6337951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A; Aguglia F; De Mattia G; Ficara C; Balsano F
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.
    Antonaccio MJ; Rubin B; Horovitz ZP; Laffan RJ; Goldberg ME; High JP; Harris DN; Zaidi I
    Jpn J Pharmacol; 1979 Apr; 29(2):285-94. PubMed ID: 231700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.
    Case DB; Atlas SA; Sullivan PA; Laragh JH
    Circulation; 1981 Oct; 64(4):765-71. PubMed ID: 6168412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.